Impact of pharmacist intervention on diabetes patients in an ambulatory setting

Diabetes Spectrum

Volumn 22, Issue 4, 2009, Pages 241-246

  Stading, Julie ^a,b   Herrmann, Jamie ^c   Walters, Ryan ^d   Destache, Chris ^d   Chock, Alan ^a,e  

^a CREIGHTON UNIVERSITY   (United States)

^b Veterans Administration Nebraska Western Iowa Health Care System (NWIHCS VA)   (United States)

^c NWIHCS VA   (United States)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NWIHCS VA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; ISOPHANE INSULIN; LOW DENSITY LIPOPROTEIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACIST; SYSTOLIC BLOOD PRESSURE; TEAMWORK;

EID: 73849147207     PISSN: 10409165     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaspect.22.4.241     Document Type: Article

References (18)

1. National Center for Health Statistics: National diabetes fact sheet, 2007 [article online]. Available from http://www.cdc.gov/diabetes/pubs/pdf/ndfs- 2007.pdf. Accessed 27 February 2008
2. American Diabetes Association: Standards of medical care in diabetes - 2009. Diabetes Care 32 (Suppl. 1)S13-S61, 2009
3. McCord AD: Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy 26:248-253, 2006
4. Cioffi ST, Caron MF, Kalus JS, Hill P, Buckley TE: Glycosylated hemoglobin, cardiovascular and renal outcomes in a pharmacist-managed clinic. Ann Pharmacother 38:771-775, 2004
5. Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HG: A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy 22:1294-1300, 2002
6. Rothman R, Malone R, Bryant B, Horlen C, Pignone M: Pharmacist led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes. Am J Med Qual 18:51-58, 2003
7. Gerber RA, Liu G, McCombs JS: Impact of pharmacist consultations provided to patients with diabetes on healthcare costs in a health maintenance organization. Am J Manag Care 4:991-1000, 1998
8. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 26 (Suppl. 1):S33-S50, 2003
9. U.K. Prospective Diabetes Study Group: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000
10. U.K. Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-854, 1998
11. ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560-2572, 2008
12. ACCORD Study Group: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559, 2008
13. Stevens J: Applied Multivariate Statistics for the Social Sciences. 2nd ed. Hillsdale, N.J., Lawrence Erlbaum Associates, 1991
14. Cohen J: Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, N.J., Lawrence Erlbaum Associates, 1988
15. D'Amico EJ, Neilands TB, Zambarano R: Power analysis for multivariate and repeated measures designs: a flexible approach using the SPSS MANOVA procedure. Behav Res Methods Instrum Comput 33:479-484, 2001
16. Smithson MJ: Confidence Intervals. Belmont, Cailf., Sage, 2003
17. U.K. Prospective Diabetes Study Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-866, 1998
18. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progress of long-term complications in insulin-dependent diabetes. N Engl J Med 329:977-986, 1993